Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In June 2021, the FDA approved a semaglutide for obese and overweight patients with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol) under the brand name Wegovy
They were given 2.4mg of once-weekly subcutaneous semaglutide injections or a placebo over 64 weeks
At Transform Health Creations, we start clients with a low semaglutide injection dose for weight loss, then increase it step-by-step based on your response and comfort level
YOUR PATH FORWARD What's Next Wegovy Coverage: Other Major Insurers See how other insurers compare on Wegovy coverage: Blue Cross Blue Shield Major 2026 coverage restrictions announced Cigna Often covers with step therapy requirements Aetna Most plans cover with prior authorization Anthem Blue Cross Separate policies from other BCBS affiliates Humana Coverage varies
US$ 25.89
US$ 25.97
US$ 25.62
